Workflow
威高血净：关于对合营企业同比例增资暨关联交易的公告
Shandong Weigao Blood Purification ProductsShandong Weigao Blood Purification Products(SH:603014) Zheng Quan Ri Bao Zhi Sheng·2025-11-20 12:44

Core Points - Weigao Blood Purification announced on November 20 that it has approved a proposal for proportional capital increase in its joint venture with Tailormade (China) Investment Co., Ltd. [1] - The company plans to increase its investment by 72.5 million RMB in Weigao Tailormade (Weihai) Medical Products Co., Ltd. [1] - This capital increase does not require approval from the company's shareholders' meeting. [1]